0001140361-20-026646.txt : 20201125
0001140361-20-026646.hdr.sgml : 20201125
20201125192607
ACCESSION NUMBER: 0001140361-20-026646
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201119
FILED AS OF DATE: 20201125
DATE AS OF CHANGE: 20201125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sooch Mina
CENTRAL INDEX KEY: 0001674006
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34079
FILM NUMBER: 201352442
MAIL ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ocuphire Pharma, Inc.
CENTRAL INDEX KEY: 0001228627
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113516358
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 37000 GRAND RIVER AVE.
STREET 2: SUITE 120
CITY: FARMINGTON HILLS
STATE: MI
ZIP: 48335
BUSINESS PHONE: 248-681-9815
MAIL ADDRESS:
STREET 1: 37000 GRAND RIVER AVE.
STREET 2: SUITE 120
CITY: FARMINGTON HILLS
STATE: MI
ZIP: 48335
FORMER COMPANY:
FORMER CONFORMED NAME: REXAHN PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20050516
FORMER COMPANY:
FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC
DATE OF NAME CHANGE: 20030423
4
1
form4.xml
FORM 4
X0306
4
2020-11-19
0001228627
Ocuphire Pharma, Inc.
OCUP
0001674006
Sooch Mina
C/O OCUPHIRE PHARMA, INC.
37000 GRAND RIVER AVE, SUITE 120
FARMINGTON HILLS
MI
48335
true
true
President and CEO
Common Stock
2020-11-19
4
P
0
11524
A
800044
D
Series A Warrant (right to buy)
4.4795
2020-11-19
4
P
0
17413
A
2020-11-19
2025-11-19
Common Stock
17413
17413
D
Series B Warrant (right to buy)
0.0001
2020-11-19
4
P
0
2046
A
2020-11-19
2022-01-28
Common Stock
2046
2046
D
The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $65,000.
Subject to adjustment based on certain price reset provisions.
/s/ Emily J. Johns, by Power of Attorney
2020-11-25